Subgroup analysis of the impact of the glycoprotein IIb/IIIa inhibitor abciximab in patients undergoing elective stent placement >2 hours after treatment with a 600 milligram loading dose of clopidogrel:: Results from the ISAR REACT trial

[摘要]

[发布日期] 2004-03-03